Award
West Virginia University 1R56ES035719-01A1
Xanthine oxidase mediates the vascular dysfunction with direct and in-utero electronic cigarette exposure
Recipient
West Virginia University
Award Amount
$619,477.00
Ceiling
$619,477.00
Awarded
August 29, 2024
Identifier
1R56ES035719-01A1
NIH awarded a grant to West Virginia University for research on xanthine oxidase's role in vascular dysfunction caused by electronic cigarette exposure, including in utero effects, with a budget of $619,477 for 2024-2026.
Description
This project focuses on the role of xanthine oxidase in vascular dysfunction related to electronic cigarette exposure, including in utero effects. It involves NIH grant PA-20-185, with a budget of approximately $619,477 for the period from September 1, 2024, to August 31, 2026. The project emphasizes understanding molecular mechanisms and potential interventions such as febuxostat to delay disease progression.